Estrella Immunopharma, Inc. , a preclinical-stage biopharmaceutical company, develops T-cell therapies for blood cancers and solid tumors in the United States.
Estrella Immunopharma stock last closed at $0.96, down 4.95% from the previous day, and has increased 1.05% in one year. It has overperformed other stocks in the Biotechnology industry by 0.77 percentage points. Estrella Immunopharma stock is currently +52.38% from its 52-week low of $0.63, and -70.28% from its 52-week high of $3.23.
As of Jun 13, 2025, there are 36.17M shares of ESLA outstanding. The market capitalization of ESLA is $34.72M. In the past 24 hours, 18,000 ESLA shares were traded.
You will need an online brokerage account to access the NASDAQ market and buy ESLA shares.
We believe that eToro is the best brokerage. eToro gives you:
Get $10 towards your purchase of shares by signing up for an account with eToro now. This offer is only for US users.
Open eToro AccountNow that you've chosen the best brokerage, you need to fill out some personal details so you are able to invest in ESLA today.
Now that you've finished signing up on a mobile trading app, you need to deposit funds:
Check out the video below for more details transferring money into your investment account.
Once you have decided on the best place to buy Estrella Immunopharma stock, it's important to evaluate their stock before you invest, so you can understand the risk and upside.
WallStreetZen was designed to help everyday investors perform better fundamental analysis quickly.
You can see all of the due diligence checks on ESLA's stock page.
Investors use a variety of different financial metrics, analyses, models, and charts to gauge ESLA's true value.
You can do additional valuation research on ESLA's stock here.
Out of 1 Equities analysts who monitor ESLA, the consensus analyst rating on ESLA is a Strong Buy
Please note that analyst forecasts are not recommendations, nor are they investment advice.
You can dive deeper into what analysts are forecasting on the Estrella Immunopharma stock forecast page.
Over the past 12 months, executives and large shareholders at ESLA have not bought or sold any shares.
Get more info about who owns ESLA shares here.
No, Estrella Immunopharma doesn't provide an income stream by paying out dividends.
One of the biggest reasons eToro is our favorite brokerage is because of its social trading community.
Click below to find out what other community members have to say.
There are two primary types of orders:
Press the Open button and your broker will place the order.
If you require additional help with investing in stocks on eToro, click the how to video below:
Now that you own some shares in ESLA, you'll want to keep up with your new stock purchase.
Make a watchlist to track the latest developments regarding your ESLA stock.
To reiterate, here are the 6 steps to buy Estrella Immunopharma stock:
If you are looking for a brokerage, eToro is our recommended option.
Get Started with eToro TodayIf you would like to get the latest news on your investment in Estrella Immunopharma, click the button below.